AI Science Tracker
EN

A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients.

Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China · 29 Mar 2025 · medicine

Discovery

A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients.

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary article develops and internally validates a dynamic nomogram using machine-learning/statistical predictors for one-year cardiac injury risk after antitumor therapy in 1,386 lung-cancer patients. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.

Technology: Machine-learning/statistical modeling identifies predictors and builds the online nomogram.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning/statistical modeling identifies predictors and builds the online nomogram.
Test and result
Training and validation AUC values of 0.85 and 0.86 are reported for cardiac-injury prediction.
Limitation / still unknown
The retrospective cohort includes explicit internal validation and clinical-utility analyses.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s40959-025-00328-3

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.